Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yi, Zhenghui ^a   Li, Zezhi ^a   Yu, Shunying ^a   Yuan, Chengmei ^a   Hong, Wu ^a   Wang, Zuowei ^a   Cui, Jian ^b   Shi, Tieliu ^b,c   Fang, Yiru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; BIOLOGICAL MARKER; COMPLEMENTARY RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR DEPRESSION; MALE; ONSET AGE; SUBSYNDROMAL SYMPTOMATIC DEPRESSION; SUPPORT VECTOR MACHINE; SYMPTOMATOLOGY; SYNDROME DELINEATION; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; HUMAN GENOME; METHODOLOGY; MICROARRAY ANALYSIS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; LEUKOCYTES; MICROARRAY ANALYSIS; RNA, COMPLEMENTARY; SUPPORT VECTOR MACHINES;

EID: 84863142225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031283     Document Type: Article

References (50)

1. Blazer DG, (2000) Mood Disorders:Epidemiology. In: Sadock BJ, Sadock VA, editors. Comprehensive Textbook of Psychaitry 7th Edition Philadephia Lippincott Williams & Wilkins pp. 1298-1308.
2. Davidson JR, Meltzer-Brody SE, (1999) The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 60: 4-9.
3. Baumeister H, (2010) A clinical significance criterion is essential for diagnosing subthreshold depression. Am J Psychiatry 167: 866.
4. Ayuso-Mateos JL, Nuevo R, Verdes E, Naidoo N, Chatterji S, (2010) From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry 196: 365-371.
5. Karsten J, Hartman CA, Ormel J, Nolen WA, Penninx BW, (2010) Subthreshold depression based on functional impairment better defined by symptom severity than by number of DSM-IV symptoms. J Affect Disord 123: 230-237.
6. American Psychiatric Association (2001) Diagnostic and Statistical Manual of Mental Disorder, 4th ed Washington, DC American Psychiatric Association.
7. Judd LL, Rapaport MH, Paulus MP, Brown JL, (1994) Subsyndromal symptomatic depression: a new mood disorder? J Clin Psychiatry 55: s18-s28.
8. Judd LL, Akiskal HS, Paulus MP, (1997) The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disorders 45: 5-18.
9. Chuan SK, Kumar R, Matthew N, Heok KE, Pin NT, (2008) Subsyndromal depression in old age: clinical significance and impact in a multi-ethnic community sample of elderly Singaporeans. International Psychogeriatrics 20: 188-200.
10. Forsell Y, (2007) A three-year follow-up of major depression, dysthymia, minor depression and subsyndromal depression: result from a population-based study. Depress Anxiety 24: 62-65.
11. Goldney RD, Fisher LJ, Dal Grande E, Taylor AW, (2004) Subsyndromal depression: prevalence, use of health services and quality of life in an Australian population. Soc Psychiatry Psychiatr Epidemiol 39: 293-298.
12. Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, et al. (1994) Subthreshold depression and depressive disorder.clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry 151: 1777-1784.
13. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, et al. (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55: 694-700.
14. Maier W, Gansicke M, Weiffenbach O, (1997) The relationship between major and subthreshold variants of unipolar depression. J Affect Disord 45: 41-51.
15. Sullivan PF, Neale MC, Kendler KS, (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157: 1552-1562.
16. Mehta D, Menke A, Binder EB, (2010) Gene expression studies in major depression. Curr Psychiatry Rep 12: 135-144.
17. Atz M, Walsh D, Cartagena P, Li J, Evans S, et al. (2007) Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 163: 295-309.
18. Popova T, Mennerich D, Weith A, Quast K, (2008) Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues. BMC Genomics 9: 91.
19. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, et al. (2011) Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16: 751-762.
20. Kang HJ, Adams DH, Simen A, Simen BB, Rajkowska G, et al. (2007) Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci 27: 13329-13340.
21. Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, et al. (2004) Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A 101: 15506-15511.
22. Thase ME, (2000) Mood Disorders:Neurobiology. In: Sadock BJ, Sadock VA, editors. Comprehensive Textbook of Psychaitry 7th Edition Philadephia Lippincott Williams & Wilkins pp. 1318-1328.
23. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA, (2006) The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147: 126-132.
24. Sullivan PF, Fan C, Perou CM, (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141: 261-268.
25. Shimojo M, Imai Y, Nakajima K, Mizushima S, Uemura A, et al. (1993) Interleukin-2 enhances the viability of primary cultured rat neocortical neurons. Neurosci Lett 151: 170-173.
26. Gladkevich A, Kauffman HF, Korf J, (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28: 559-576.
27. Pariante CM, Miller AH, (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49: 391-404.
28. Ma J, Liew CC, (2003) Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 35: 993-998.
29. Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, et al. (2004) Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 170: 911-919.
30. Lampe JW, Stepaniants SB, Mao M, Radich JP, Dai H, et al. (2004) Signatures of environmental exposures using peripheral leukocyte gene expression: Tobacco smoke. Cancer Epidemiol Biomarkers Prev 13: 445-453.
31. Marshall A, Hodgson J, (1998) DNA chips: An array of possibilities. Nature Biotechnology 16: 731.
32. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, et al. (1993) Multiplexed biochemical assays with biological chips. Nature 364: 555-556.
33. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, et al. (2005) Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 133: 1-5.
34. Segman RH, Goltser-Dubner T, Weiner I, Canetti L, Galili-Weisstub E, et al. (2010) Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry 15: 93-100.
35. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, et al. (2009) Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 14: 156-174.
36. Spijker S, Van Zanten JS, De Jong S, Penninx BW, van Dyck R, et al. (2010) Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry 68: 179-186.
37. Rajkowska G, (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48: 766-777.
38. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS, (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22: 3251-3261.
39. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS, (2007) A role for MAP kinase signaling in behavioral models depression and antidepressant treatment. Biol Psychiatry 61: 661-670.
40. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, et al. (2007) Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci U S A 104: 8131-8136.
41. Sokolov BP, (2007) Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int J Neuropsychopharmacol 10: 547-555.
42. Barley K, Dracheva S, Byne W, (2009) Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res 112: 54-64.
43. Madia F, Frisullo G, Nociti V, Conte A, Luigetti M, et al. (2009) pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 14: 107-117.
44. Reiche EM, Nunes SO, Morimoto HK, (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5: 617-625.
45. Le Hellard S, Mühleisen TW, Djurovic S, Fernø J, Ouriaghi Z, et al. (2010) Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol Psychiatry 15: 463-472.
46. Pandey GN, Rizavi HS, Dwivedi Y, Pavuluri MN, (2008) Brain-Derived Neurotrophic Factor Gene Expression in Pediatric Bipolar Disorder: Effects of Treatment and Clinical Response. J Am Acad Child Adolesc Psychiatry 47: 1077-1085.
47. Katsel P, Davis KL, Haroutunian V, (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79: 157-173.
48. Sun J, Jia P, Fanous AH, van den Oord E, Chen X, et al. (2010) Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS One 5: e11351.
49. Struyf J, Dobrin S, Page D, (2008) Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia. BMC Genomics 9: 531.
50. Bean AJ, Dagerlind A, Hökfelt T, Dobner PR, (1992) Cloning of human neurotensin/neuromedin N genomic sequences and expression in the ventral mesencephalon of schizophrenics and age/sex matched controls. Neuroscience 50: 259-268.